Substance abuse treatment organizations as mediators of social policy: Slowing the adoption of a congressionally approved medication

Journal of Behavioral Health Services and Research

Volumn 37, Issue 1, 2010, Pages 64-78

  Wallack, Stanley S ^a   Thomas, Cindy Parks ^a   Martin, Timothy C ^a   Chilingerian, Jon ^a   Reif, Sharon ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

Buprenorphine; Organizational culture; Technology adoption

Indexed keywords

BUPRENORPHINE; NARCOTIC ANTAGONIST;

ARTICLE; ATTITUDE TO HEALTH; COMMUNITY CARE; DRUG DEPENDENCE TREATMENT; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; HEALTH CARE SURVEY; HUMAN; MASS COMMUNICATION; NONBIOLOGICAL MODEL; OPIATE ADDICTION; ORGANIZATION; ORGANIZATION AND MANAGEMENT; POLICY; POLITICS; REGRESSION ANALYSIS;

BUPRENORPHINE; COMMUNITY HEALTH SERVICES; DIFFUSION OF INNOVATION; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MODELS, ORGANIZATIONAL; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; ORGANIZATIONAL CULTURE; POLITICS; PUBLIC POLICY; REGRESSION ANALYSIS; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 76049107426     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11414-008-9132-4     Document Type: Article

References (56)

1. J Newhouse 1992 How much welfare loss? Journal of Economic Perspectives 6 3 3021
2. EA Belongia B Schwartz 1998 Strategies for promoting judicious use of antibiotics by doctors and patients British Medical Journal 317 5 668 671 1:STN:280:DyaK1czpslarug%3D%3D 9728003
3. J Ma N Sehgal JZ Ayanian, et al. 2005 National trends in statin use by coronary heart disease category PLoS Medicine 2 5 e123 10.1371/journal.pmed. 0020123 15916463 (Pubitemid 40973530)
4. RS Stafford V Monti J Ma 2005 Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease PLoS Medicine 2 12 e353 10.1371/journal.pmed.0020353 16277554 (Pubitemid 43020988)
5. Tichy NM. Networks in Organizations. New York: Oxford University Press; 1981.
6. LJ Ducharme HK Knudsen PM Roman 2006 Evidence-based treatment for opiate-dependent clients: availability, variation, and organizational correlates The American Journal of Drug and Alcohol Abuse 32 569 576 10.1080/ 00952990600920417 17127545 (Pubitemid 44870995)
7. WK Bickel ML Stitzer GE Bigelow, et al. 1988 A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts International Journal of Clinical Pharmacology and Therapeutics 43 72 78 1:STN:280:DyaL1c%2FotFaqtg%3D%3D
8. RE Johnson JH Jaffe PJ Fudala 1992 A controlled trial of buprenorphine treatment for opioid dependence Journal of American Medical Association 267 2750 2755 10.1001/jama.267.20.2750 1:STN:280:DyaK383ltF2gtw%3D%3D
9. T Kosten R Schottenfeld D Ziedonis, et al. 1993 Buprenorphine versus methadone maintenance for opioid dependence Journal of Nervous and Mental Diseases 181 358 364 10.1097/00005053-199306000-00004 1:STN:280: DyaK3s3nsVarug%3D%3D (Pubitemid 24259606)
10. National Institutes of Health 1998 National consensus development panel on effective medical treatment of opiate addiction, Effective medical treatment of opiate addiction Journal of American Medical Association 280 22 1936 1946 10.1001/jama.280.22.1936
11. KE McCollister MT French 2003 The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings Addiction 98 12 1647 1659 10.1111/j.1360-0443.2003.00541.x 14651494 (Pubitemid 38030770)
12. JS Coleman E Katz, et al. 1957 The diffusion of an innovation among physicians Sociometry 20 253 270 10.2307/2785979
13. Starbuck WH. Organizations and Their Environments. Chicago, IL: Rand McNally; 1976.
14. Rogers E. Diffusion of Innovations, 5th Edition. New York: Simon & Schuster; 1995.
15. Kadushin C. Frontiers of Research in Network Theory and Method. New York: CUNY Graduate Center; 1979.
16. JA Chilingerian M Glavin 1994 Temporary firms in community hospitals: elements of a managerial theory of clinical efficiency Medical Care Research and Review 51 289 335 10.1177/107755879405100303 1:STN:280:DyaK2M%2Flslelug%3D%3D
17. Fendrick M, Schwartz JS. Physicians' Decisions Regarding the Acquisition of New Technology. Washington, DC: National Academy; 1994.
18. CP Thomas S Wallack S Lee, et al. 2003 Research to practice: adoption of naltrexone in alcoholism treatment Journal of Substance Abuse Treatment 24 1 11 10.1016/S0740-5472(02)00319-7 12646325 (Pubitemid 36315767)
19. WR Scott 1993 The organization of medical care services: toward an integrated theoretical model Medicare Care Review 50 3 271 303 10.1177/002570879305000303 1:STN:280:DyaK2c%2FhvVSgsw%3D%3D
20. SAMHSA. Results from the 2004 National Survey on Drug Use and Health: Detailed Tables. Accessed online: http://oas.samhsa.gov/NSDUH/2k4nsduh/2k4tabs/ 2k4tabs.pdf 2006.
21. D McCarty RG Frank GC Denmead 1999 Methadone maintenance and state Medicaid managed care programs The Milbank Quarterly 77 3 341 362 10.1111/1468-0009.00139 1:STN:280:DyaK1MvlsFClug%3D%3D 10526548
22. Office Of Applied Studies, eds. Substance Abuse and Mental Health Services Administration. N-SSATS 2004 (United States). Arlington, VA: Synectics for Management Decisions (producer); Ann Arbor, MI: Inter-university Consortium for Political and Social Research (distributor); 2005:11-14.
23. DR Jasinski JS Pevnick JD Griffith 1978 Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction Archives of General Psychiatry 35 4 501 516 1:CAS:528:DyaE1cXktFOitbw%3D 215096
24. PD Law JE Bailey DS Allen, et al. 1997 The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting Addiction Biology 2 191 200 10.1080/13556219772732 (Pubitemid 27183104)
25. Institute of Medicine. Bridging the Gap Between Practice and Research: Forging Partnerships with Community-based Drug and Alcohol Treatment. Washington, DC: National Academy; 1998.
26. TL Mark HR Kranzler X Song, et al. 2003 Physicians' opinions about medications to treat alcoholism Addiction 98 617 626 10.1046/j.1360-0443.2003. 00377.x 12751979 (Pubitemid 36638200)
27. Etzioni A. A Comparative Analysis of Complex Organizations. New York: Free; 1961.
28. PM Roman JA Johnson 2002 Adoption and implementation of new technologies in substance abuse treatment Journal of Substance Abuse Treatment 22 211 218 10.1016/S0740-5472(02)00241-6 12072165 (Pubitemid 34606039)
29. DA Conrad JB Christianson 2004 Penetrating the "black box": financial incentives for enhancing the quality of physician services Medical Care Research and Review 61 3 Suppl 37S 68S 10.1177/1077558704266770 15375283 (Pubitemid 39096576)
30. Institute of Medicine. Crossing the Quality Chasm, A New Health System for the 21st Century. Washington, DC: National Academy; 2001.
31. MB Rosenthal RG Frank L Zhonghe, et al. 2005 Early experience with pay-for-performance from concept to practice Journal of American Medical Association 294 14 1788 1793 10.1001/jama.294.14.1788 1:CAS:528: DC%2BD2MXhtFWgsLrF (Pubitemid 41434625)
32. SM Shortell JL Zazzali LR Burns, et al. 2001 Implementing evidence-based medicine the role of market pressures, compensation incentives, and culture in physician organizations Medical Care Research and Review 39 7, Physician-System Alignment Supplement 162 178
33. Argyris C, Schon DA. Organizational Learning. Reading, MA: Addison-Wesley; 1978.
34. Cyert RM, March JG. A Behavioral Theory of the Firm. Englewood Cliffs, NJ: Prentice Hall; 1963.
35. M Granovetter 1985 Economic action and social structure: the problem of embeddedness American Journal of Sociology 91 53 81 10.1086/228311
36. Lawrence PR, Lorsch JW. Organization and Environment. Boston, MA: Graduate School of Business Administration, Harvard University; 1967.
37. March JG, Simon HA. Organizations. New York: Wiley; 1958.
38. Taylor FW. The Principles of Scientific Management. New York: Harper & Row; 1947.
39. Tichy NM. Managing Strategic Change. New York: Wiley; 1983.
40. Tichy NM, Devanna MA. The Transformational Leader. New York: Wiley; 1990.
41. Schein E. Organizational Culture and Leadership. 2nd edn. San Francisco, CA: Jossey-Bass; 1997.
42. Bacharach SB. Power and Politics in Organizations. San Francisco, CA: Jossey-Bass; 1980.
43. Chilingerian JA. Origins of DRGS in the United States: a technical, political and cultural story. In: Kimberly J, ed. The Globalization of Managerial Innovation: The Interplay of Politics, Policy and Functionality in Health Care. Cambridge: Cambridge University Press; 2008.
44. March JG. Ambiguity and Choice in Organizations. Bergen, Norway: Universitetsforlaget; 1976.
45. Schein E. What is culture? In: Frost PLM, Lousi M, Lundberg C, Martin J, eds. Reframing Organizational Culture. Thousand Oaks: Sage; 1991:10.
46. ML Willenbring D Kivlahan M Kenny, et al. 2004 Beliefs about evidence-based practices in addiction treatment: a survey of Veterans Administration program leaders Journal of Substance Abuse Treatment 26 79 85 10.1016/S0740-5472(03)00161-2 15050084 (Pubitemid 38402016)
47. MD Cohen JG March 1972 A garbage can model of organizational choice Administrative Science Quarterly 17 1 25 10.2307/2392088
48. House R, Baetz M. Leadership: some empirical generalizations and new research. In: Staw B, ed. Research in Organizational Behavior. Greenwich: JAI; 1979:341-423.
49. T D'Aunno TE Vaughn 1992 Variations in methadone treatment practices. Results from a national study Journal of American Medical Association 257 2 281 282
50. Office of Applied Studies, eds. Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services (N-SSATS): 2003. Vol DASIS Series: S-24: Data on Substance Abuse Treatment Facilities; 2004.
51. JH Gittell 2002 Coordinating mechanisms in care provider groups: relational coordination as a mediator and input uncertainty as a moderator of performance effects Management Science 48 11 1408 1426 10.1287/mnsc.48.11.1408. 268
52. JH Gittell K Fairfield, et al. 2000 Impact of relational coordination on quality of care, post-operative pain and functioning, and length of stay: a nine hospital study of surgical patients Medical Care 38 8 807 819 10.1097/00005650-200008000-00005 1:STN:280:DC%2BD3czpslymuw%3D%3D 10929993
53. GA Marlatt 1996 Harm reduction: come as you are Addictive Behaviors 21 6 778 788 10.1016/0306-4603(96)00042-1 (Pubitemid 26330615)
54. J Michaels M Galanter R Resnick, et al. 1995 Community based heroin addicts who turn to experimental treatment rather than conventional care Journal of Addictive Diseases 14 2 33 42 10.1300/J069v14n02-04 1:STN:280: DyaK28%2FntlOltA%3D%3D 8541358
55. Advancing Recovery. www.advancingrecovery.net. Accessed March 3, 2008.
56. Thomas CP, Reif S, Haq S, et al. Adoption of buprenorphine by psychiatrists and addiction specialists: results of a national survey. Psychiatric Services (in press).